New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.

The executive order instructs the FDA to expedite the approval process for domestic pharmaceutical manufacturing facilities.

“This is the first step towards the use of gene editing therapies to treat a wide variety of rare genetic disorders for which ...

Another Breakthrough Summit West in the books, and what an excellent event! We kicked off the day with former FDA head Robert ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

The signs of diabetes in kids include increased thirst, frequent urination, and irritability. Learn more signs and when to ...

The agency announced on May 13 that it intends to remove prescription fluoride tablets and drops, citing potential links to ...

Consumers who have purchased the affected product (especially those with an allergy or sensitivity to tree nuts) should not consume it, per the FDA. Anyone in possession of Bonya-branded yogurt ...

The company has been accused of illegally misrepresenting some of its cereals, such as Trix and Lucky Charms, as “healthy.” ...

Cash expected to fund operations into the second half of 2026Advancing development strategy for lead program TPI 287 to commence Phase 2 study around year end 2025 for treatment of glioblastoma ...

US biopharma companies outsource 30 percent of their FDA-approved manufacturing processes to Chinese contract drugmakers, ...